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ABSTRACT
The aim of this study was to evaluate the value of MRI spectroscopy and association with the altered 
glucose metabolism on 18-FDG PET/CT in patients with suspicious breast cancer. Eight selected breast 
cancer patients with BIRADS 4 or 5 on mammogram were recruited and patients underwent 18F-FDG 
PET/CT MRI (spectroscopy). The standardise uptake value (SUVmax) was analysed to determine the 
degree of the altered glucose metabolism on the PET. The metabolites of tumor lesions were measured 
using in vivo proton MR spectroscopy (MRS) of the breast. There were eight females with a mean age of 
55.3±12.2 years with a biopsy result of invasive ductal carcinoma (2), lobular carcinoma (1) and benign 
lesion (5). There was a significant difference between the mean of the malignant tumour (SUVmax 
4.28±3.74 g/ml) and the mean of the benign tumour (SUVmax: 2.33±0.9 g/ml). On the per-lesional basis 
of the MRS correlate with SUVmax, the suspicious breast tissue exhibited raised creatinine metabolites 
(mean: 3.39±0.54u) with significant correlation SUVmax mean 3.06±2.34 as compared to N-acetyl 
Aspartate (NAA), (mean: 2.84±0.99u) and choline (mean: 2.46± 0.70 u). This study showed that high 
SUVmax was associated with malignant cancer and the high creatinine metabolite that correlated with 
the SUVmax could potentially be utilised as a surrogate marker in detecting breast cancer.   
Keywords: Magnetic Resonances Imaging Spectroscopy, Computed tomography, positron emission 
tomography, [18F]-fluorodeoxyglucose, multimodality
INTRODUCTION
Worldwide, breast cancer is becoming a 
leading cause of death. Mortality due to 
breast cancer increased from 20,100 deaths 
in 2008 to 21,700 deaths in 2012 worldwide, 
as reported by the International Agency for 
Research on Cancer (IACR) Globocan of the 
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World Health Organisation (WHO). The risk factors that contribute to breast cancer include 
hormone replacement therapy for a long period of time, being overweight especially after 
menopause and mutations in cancer-related genes (erbB2). Recent studies found that the 
development of cancer was due to choline intake (Zhang et al., 2013).
In breast cancer cells, the level of choline was found markedly higher compared 
to in normal human mammary epithelial cells (Aoyama et al., 2004). Both choline 
phosphorylation and transport were found to be augmented in human breast cancer cells 
(Cho et al., 2007). Overexpression of choline kinase (CK) will induce progression of human 
mammary epithelial cells from a normal to a malignant phenotype. These choline kinase will 
catalyse the phosphorylation of choline to form phosphocholine, followed by generation of 
phosphatidylcholine in tumor cell membranes (Molina et al., 2004). Recent studies proved that 
choline kinase, which transforms choline to phosphocholine (PCho), was increased in malignant 
tumours and caused progression of mammary epithelial cells in vitro (Ramirez et al., 2004).
In vivo proton MR spectroscopy (1H-MRS) is a non-invasive technique that has great 
potential to generate tumor metabolism, which is a useful process in evaluation and diagnosis 
of the response to treatment of tumour progression (Meisamy et al., 2004). Recently, breast 
1H-MRS has been shown to improve cancer diagnosis based on elevated choline-containing 
compounds’ (tCho) metabolite peak (Baek et al., 2008). Several researchers have found that 
1.5T of in vivo 1H-MRS can be used to detect and distinguish between malignant and benign 
cancer tissue (Baik et al., 2006). Nowadays, FDG ia used to detect tumour progression by 
providing useful information about tumor characterisation, staging, patient prognosis and 
monitor response of anticancer therapy to patients with suspected malignancies. Besides that, 
FDG uptake correlates with tumour growth and viability in recent studies (Fathinul Fikri et al., 
2014). A combination of non-invasive imaging techniques of Positron Emission Tomography 
(PET) and MRI are beneficial in detecting the response to treatment to target tumours using 
the metabolics of choline. The aim of this study was to evaluate the value of metabolic MRI 
spectroscopy and its association with altered glucose metabolism on FDG-18 PET/CT in 
patients suspected of developing breast cancer tissue as evaluated by the BIRADS scoring 
system. 
MATERIALS AND METHODS
Patient Selection
In the prospective group, eight selected breast cancer patients with mammogram results 
showed BIRADS 4 or 5, recurrent breast cancer and biopsy results with proven breast mass 
were recruited from an endocrinology clinic. Patients undergoing chemotherapy or who had 
undergone surgery were excluded from the studies. All the patients underwent 18F-FDG PET 
CT and MRI spectroscopy prospectively. All the patients who participated in this study gave 
written consent before commencement of the study. 
Patient preparation. All the patients were required to fast from food consumption for at 
least 6 hr before examination. The fasting blood glucose level was measured in the morning 
and followed by injection of the tracer of 8-10mCi of 18F-FDG intravenously. The patients 
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were required to rest with an uptake time approximately 60 min in a confinement room before 
examination. All the patients underwent MRI imaging first, followed by PET-CT imaging 
studies according to standard protocol.
Imaging Technique
18F-FDG. The dedicated integrated PET-CT system (Siemens Biograph-64, Germany) was 
used to standardise the value of 18F-FDG uptake. This dedicated PET scanner with optimum 
performance in 3-D Imaging using Lutetium Oxyyorthosilicate (LSO) scintillator crystal 
technology was used to provide efficient rejection of random events, fast coincidence timing, 
high count rates and high light output. The device was incorporated with a multislice CT 
scanner with capability for high spatial resolution and a 64-slice CT. For higher sensitivity, 
the acquisition time for PET using this system was calibrated using a 2-min-per-table position. 
The CT data were resized from a 512x512 matrix to a smaller matrix, 128x128, to match the 
PET data to allow the fusion image and CT transmission map to be generated. Ordered-subsets 
expected maximisation (OSEM) was used to reconstruct the PET images with segmented 
measurement of attenuation correction using CT data with four iterations and 16 subsets. Post 
reconstruction smoothing of images was performed using a 5-mm FWHM Gaussion filter. The 
PET and CT images were then fused, creating an image of distributed 18F-FDG overlying the 
corresponding anatomy and physiology generated using a dedicated workstation.
MRI spectroscopy. MRI was performed using a 3.0-T system (Prisma, Siemens Heatlcare). 
All patients were examined in a prone position. A bosy coil was used for transmission and a 
double-breast coil (4-element Breast Matrix Coil, Siemens Helathcare) was used for the MR 
spectroscopy. All the MRI sequence steps were performed using a single-voxel 1H MRS with a 
point-resolved spectroscopy sequence (PRESS). The parameter of MRS was 1,620/270;voxel 
size 10x10x10 mm3; 256 acquisitions; spectral width 1000Hz; 1,024 data points; and the time 
of acquisition, 7 min. For voxel placement, coronal and sagittal positions were used as scout 
images, and a voxel of interest was placed to include the lesion. Shimming was performed 
automatically first, followed by manual shimming on the water resonance for optimisation of 
the homogeneity in each volume of interest. Water-peak line widths of 10-20Hz (full width 
at half-maximum [FWHMI]) were typically achieved. After the shimming procedure, spectra 
were acquired with water suppression by applying three chemical shift-selective excitation 
pulses. By spectral suppression using dual band-selective inversion with gradient dephasing, the 
transverse magnetisation was selectively dephased before and after the second spin-echo pulse.
Image Analysis
The PET/CT scans and MRI breast images were read and interpreted by an experienced 
radiologist with more than five years’ clinical experience, who was blinded to the history and 
diagnosis of each patient and was unaware of any clinical findings or information.
18F-FDG. The results were analysed according to the qualitative assessment on a per-lesion 
basis in each patient who had undergone the FDG-PET/CT examination. On per lesion basis, 
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the higher inherent metabolic activity was compared to the mediastinal blood pool on the 
FDG-PET/CT and the lesions were considered positive lesions. All of the reviews of the PET 
images and the determination of the PET parameter were performed via software using a setting 
that allowed maximum intensity projection (MIP) and three-dimensional displays (transaxial, 
coronal, sagittal) of PET, CT and fused PET/CT images. The SUVmax was derived from the 
mean of all the FDG-positive lesions. The CT scans were also analysed for lesion location, 
size and the pattern of regional tumour infiltration. For the quantitative assessment, a circular 
region of interest (diameter 1.5 cm) was placed over the tumour in the slice with the maximum 
SUV in the baseline scan (Figure 1).
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Figure 1. A circular region of interest (diameter 1.5 cm) was placed over the tumour in the 
slice with the maximum SUV of 3.49ug/dl. 
 
MRI spectroscopy.  The obtained spectrum represents specific metabolites appearing in 
certain frequencies due to their specific chemical shifts. The resonance spectrum identifies 
metabolites by locating their peaks. Several peaks can characterise the same compound 
(i.e. doublet or triplet). Graphic representation of acquired data includes these metabolite 
peaks (represented on the horizontal axis of the graph) expressed as parts per million (ppm) 
and their relative signal amplitude in the vertical axis. The area or integral under each peak 
represents the relative concentration of the detected metabolite (Figure 2).  
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maximum SUV of 3.49ug/dl
MRI spectroscopy. The obtained spectrum represents specific metabolites appearing in certain 
frequencies due to their specific chemical shifts. The resonance spectrum identifies metabolites 
by locating their peaks. Several peaks can characterise the same compound (i.e. doublet or 
triplet). Graphic representation of acquired data includes these metabolite peaks (represented 
on the horizontal axis of the graph) expressed as parts per million (ppm) and their relative 
signal amplitude in the vertical axis. The area or integral under each peak represents the relative 
concentration of the detected metabolite (Figure 2). 
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Figure 2. (a) The peak of tCho with 1.41 ppm, integral at 0.08 in benign tumour. (b) The 
circular region drawn at the breast lesion with b value of 50 showed non-restricted ADC 
value of 1.65mm2/s, which was benign. 
 
Statistical Analysis 
All the patients with biopsy-proven cancer were dichotomised into groups based on 
malignant and benign cancer. Univariate descriptive analysis was carried out using socio-
demographic characteristics (age group and biopsy results). Numerical data described 
using means and standard deviation depending on the distribution of respective variables 
(Table 2). An independent t test was used to compare between the groups (Table 3). Data 
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Statistical Analysis
All the patients with biopsy-proven cancer were dichotomised into groups based on malignant 
and benign cancer. Univariate descriptive analysis was carried out using socio-demographic 
characteristics (age group and biopsy results). Numerical data described using means and 
standard deviation depending on the distribution of respective variables (Table 2). An 
independent t test was used to compare between the groups (Table 3). Data were analysed using 
the Pearson correlation coefficient. All statistics were analysed using the Statistical Package 
for Social Sciences programme for Windows 21.0 (SPSS 21) (IBM Corp, Somers, New York). 
P values <0.05 were considered statistically significant. 
Table 1 
Descriptive patient characteristics (n=8)   
Characteristic N (n=8) Percentage
Age Group (Years)
<30 1 12.5
31-40 5 62.5
41-50 2 25
Biopsy
Fibroadenamatous 3 37.5
PASH 1 12.5
Fibroadenosis 1 12.5
IDC 2 25
ILC 1 12.5
RESULTS AND DISCUSSION
Patient Characteristics
The mean age of the patients in our study was 55.3±12.2 years, with middle age of 31-40 years 
being predominant (62.5%). Most of the subjects showed BIRADS 4 majority. The biopsy 
results showed five benign  patients with three fibroadenoma, one Pseudoangiomatous Stromal 
Hyperplasia (PASH) and one fibroadenosis, while three patients showed malignant tumours with 
two Invasive Ductal Carcinoma (IDC) and one Invasive Lobular Carcinoma (ILC) (Table 1).
The relationship between biopsy with SUVmax and parameter of MRI spectroscopy. Table 
2 shows there was significant relationship between SUVmax (p<0.05) and the biopsy results; the 
mean for malignant tumours was 4.28±3.74 and the mean for benign tumours was 2.33±0.90, 
while there was no significant correlation between the biopsy results and the MRI parameters.
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Correlation between SUVmax and parameter of MRI spectroscopy.  There was significant 
and direct correlation between FDG uptake with a mean of 3.06±2.34 and the creatinine mean 
of 3.39±0.54, where p=0.02. Besides that, there was also a significant and direct correlation 
between the FDG uptake with a mean of 3.06±2.34 and the N-acetyl Aspartate (NAA) mean 
of 2.84±0.99, where p=0.05 (Table 3).
Table 2 
Relationship between biopsy with FDG uptake (SUVmax) and MRI spectrocopy using independent t test   
Biopsy n Mean Std. Deviation p value
FDG (SUVmax) malignant 3 4.28 3.74 *0.01
benign 5 2.33 0.90
MRI spectroscopy choline malignant 3 3.25 0.14 0.4
benign 5 2.00 0.34
MRI spectroscopy creatinine malignant 3 3.45 0.70 0.44
benign 5 3.39 0.52
MRI spectroscopy N-acetyl 
Aspartate (NAA)
malignant 3 2.77 1.29 0.42
benign 5 2.88 0.93
*statistical significance p<0.05
Table 3 
The correlation between FDG uptake (SUVmax) and parameter of MRI spectroscopy using Pearson 
correlation  
SUVmax vs MRI spectroscopy mean±S.D r value p value
-FDG (SUVmax) 3.06±2.34 0.16 0.32
-MRI  2.46±0.7
 spectroscopy 
 choline
-FDG (SUVmax) 3.06±2.34 0.63 *0.02
-MRI  3.39±0.54
 spectroscopy 
 creatinine
-FDG (SUVmax) 3.06±2.34 0.5 *0.05
-MRI  2.84±0.99
 spectroscopy 
 NAA
* statistical significance p<0.05
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The level of choline in the human breast cancer cells was found to be markedly higher 
than in normal human mammary epithelial cells (Aoyama et al., 2004). Both choline 
transport and phosphorylation were found to be augmented in the human breast cancer 
cells. Progression of human mammary epithelial cells from normal to malignant phenotype 
was shown to be associated with an induced overexpression of choline kinase (CK) that 
catalysed the phosphorylation of choline to form phosphocholine followed by generation of 
phosphatidylcholine in the tumour cell membranes (Molina et al., 2004). In previous studies, the 
increased choline uptake in tumour cells was mainly explained by the upregulation of choline 
kinase due to an increased demand of membrane constituents (Molina et al., 2004). Recent 
studies found that the development of cancer was due to choline intake (Zhang et al., 2013). 
Besides that, other studies have proven that CK and phosphorylcholine (PCho) production 
increased in growth factor-induced mitogenic signaling of primary human breast epithelial 
cells in response to insulin and hydrocortisone (Ramirez et al., 2004). 
Imaging of tumour cell metabolism has been remarkably successful in recent years. 
Numerous studies have demonstrated that malignant tumours can be detected with high 
sensitivity and specificity by imaging increased metabolic rates for glucose. FDG Positron 
Emission Tomography (PET) has been extensively used as an imaging biomarker for 
diagnosis (Kelloff et al., 2005) and for monitoring of treatment response in cancer patients. 
An accumulation of the radiotracer-marked glucose, in terms of 18f-fluorodeoxyglucose, 
indicates an increased metabolic activity of viable tumour cells that can be quantified by SUV 
measurements. Our studies showed that there was a significant and increased FDG uptake in 
malignant lesions with a mean of 4.28±3.74 compared to in benign lesions with a mean of 
2.33±0.90. This study showed that a high SUVmax was associated with malignant cancer.
In the mammary gland area, total choline, tCho or Cho, is considered the most important 
metabolite in proton MR spectroscopy. It has been reported that the degree of elevated choline-
containing compounds is related to the grade of the tumour, with higher levels in high-grade 
than in low-grade lesions (Baik et al., 2006). Malignant lesions are more likely to show high 
levels of choline-containing compounds compared to benign or normal breast tissues. In this 
preliminary study utilising the 3.0T MR revealed that there was insignificant relationship 
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Figure 3. Scatter plot correlating the relationship between SUVmax and creatinine using 
Pearson correlation test. 
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between biopsy results with and without choline. The mean tCho for malignant lesions is 
2.58±1.01u compared to benign lesions, with a mean of 2.39±0.82u (p>0.05). Confounding 
factors i.e. patient motion, contamination by hemorrhage and inclusion of lipids interspersed 
with stromal and inflammatory cells may affect a small preliminary sample and would not 
yield a significant statistical results. The 3.0 Tesla MRI can unveil new potential surrogate 
molecular markers for aggressive lesions.
The Positron Emission Tomography (PET) and MR methods are two clinically translatable, 
non-invasive imaging techniques that are increasingly being used to detect physiological 
changes and the response of tumors to target therapy. Based on our study, we may conclude that 
there is direct and significant correlation between SUVmax 3.06±2.34g/dl and the parameter 
of MRI spectroscopy i.e. creatinine 3.39±0.54u and N-acetyl Aspartate (NAA). The metabolite 
landscape pattern showed that the highest mean was creatinine followed by N-acetyl Aspartate 
(NAA), (mean: 2.84±0.99u) and choline (mean: 2.46±0.70u). 
The limitation of this study was its small sample size and high number of benign cases 
that made it difficult to generalise the results to the general population. Besides that, small and 
non-palpable lesions bonded to a small volume of the samples, and these were below the PET 
resolutions. Future studies are recommended to used large sample sizes with various histologic 
prognostic parameters such as nuclear grade and estrogen receptor status that can correlate 
with PET/CT and MRI spectroscopy in detecting primary breast cancer. 
CONCLUSION
This study showed that high SUVmax associated with malignant cancer and high creatinine 
metabolites that correlate with SUVmax could potentially be utilised as surrogate markers for 
suspicious lesions in detecting breast cancer lesion suspected during mammography. Thus, a 
combination PET/CT and MR spectroscopy can be used to classify breast lesion as indicating 
stability or progressive disease with potential therapeutic relevance in underpinning breast 
cancer.
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